💨 Abstract

Aurinia Pharmaceuticals Inc. (AUPH) reported a first-quarter net income of $23.3 million, reversing a loss from the same period last year. The company's revenue of $62.5 million exceeded analyst expectations. Despite an 11% decline in shares since the year's start, the stock has surged 59% over the past 12 months. The report was generated using data from Zacks Investment Research.

Courtesy: wtop.com

Summarized by Einstein Beta 🤖